Answers to Your Questions on Targeted Approaches to Nonadvanced SM Patient Management

Поделиться
HTML-код
  • Опубликовано: 12 сен 2024
  • Dr. Matthew Giannetti answers questions submitted by participants of the educational activity “Answering the Call in Nonadvanced Systemic Mastocytosis (SM): Targeted Approaches to Patient Management.” The topics covered include diagnosis, especially when SM is suspected but the serum tryptase level is normal, differentiation from hereditary alpha tryptasemia (HαT), as well as when to add avapritinib to the therapeutic regimen.
    View this program in its entirety:
    exchangecme.co...
    Links/Resources you may be interested in:
    exchangecme.co...
    exchangecme.co...
    exchangecme.co...
    ExchangeCME.com is an online community of more than 54,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state-focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences.
    By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers.
    #meded #CME #systemicmastocytosis #SM #allergy #immunology #nonadvancedsm #nonadvancedsystemicmastocytosis #indolentsystemicmastocytosis
    Follow us on social!
    twitter: / exchangecme
    facebook: / exchangecme
    linkedin: / exch. .

Комментарии •